Copeptin (CPP) has been considered as a useful marker for prediction of prognosis in heart
diseases. However, CPP has not been investigated sufficiently in cardiorenal syndrome …

Plasma content of copeptin increases with the advancement of chronic kidney disease
(CKD). The purpose of this study was to evaluate copeptin content as a potential marker of …

Purpose Copeptin has been considered as a useful marker for diagnosis and prediction of
prognosis in heart diseases. However, copeptin has not been investigated sufficiently in …

Background Copeptin has turned out to give valuable prognostic information for future
cardiovascular events. However, since its plasma concentration directly depends on renal …

Copeptin is co-synthesized with vasopressin, also known as anti-diuretic hormone, with
similar plasma levels. In the last years copeptin has been studied as a diagnostic and …

Epidemiologic studies are inconsistent regarding the association between plasma copeptin
level and heart failure (HF). The aim of this study was to perform a meta‐analysis to …

Background Cardiovascular disease (CVD) is the leading cause of death in patients with
end-stage renal disease (ESRD). We explored the relationship between CVD, plasma brain …

Objective Precise perioperative risk stratification is important in vascular surgery patients
who are at high risk for major adverse cardiovascular events (MACE) peri-and …

Background Copeptin, C-terminal segment of pro-arginine vasopressin, is expected to be a
strong novel biomarker for prognosis in acute heart failure (AHF). Aim Evaluate the …

Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is released in
response to osmotic and non-osmotic stimuli and plays a key role in many physiologic and …